Venice, FLNCT07277257Now EnrollingIRB Ready

Sjogren Syndrome With Keratoconjunctivitis Clinical Trial in Venice, FL

Access cutting-edge sjogren syndrome with keratoconjunctivitis treatment through this phase 4 clinical trial at a research site in Venice. Study-provided care at no cost to qualified participants.

Sponsored by Center For Sight

Quick Self-Assessment

See if you qualify for this Venice location

Preparing your pre-screening questions…

Expert Care in Venice

Access sjogren syndrome with keratoconjunctivitis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related sjogren syndrome with keratoconjunctivitis treatment provided free

Apply for This Venice Location

Check if you qualify for this sjogren syndrome with keratoconjunctivitis clinical trial in Venice, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Venice

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Venice site if eligible
  4. 4Begin participation

About This Sjogren Syndrome With Keratoconjunctivitis Study in Venice

This study will evaluate the effect of TRYPTYR in patients with Sjögren's syndrome-related dry eye disease. The goal is to determine whether TRYPTYR can improve symptoms and signs of dry eye in this specific patient population.

Sponsor: Center For Sight

Who Can Participate

Inclusion Criteria

Subjects must fulfill the following conditions to qualify for enrollment into the trial
Adults over 18 years old with a diagnosis of dry eye disease (DED) secondary to Sjögren's Syndrome within the past 2 years.
History of using or desiring artificial tears for DED symptoms within the past 2 months.
Unanesthetized Schirmer's Test (UA ST) score ≥1 and \< 10 mm/5 min and baseline total Corneal Fluorescein Staining (tCFS) score ≥2 and ≤ 15 (National Eye Institute, NEI, grading scale).

Exclusion Criteria

Subjects with any of the following conditions on the eligibility exam may NOT be enrolled into the trial.
History of ocular surgery within the past 6 months.
Contact lens wear in either eye within 7 days of visit 1 (baseline) or use during study
On current topical treatment regimen for less than 3 months or anticipates any change to the regimen during the study period.
Use of topical steroid ocular medication or varenicline nasal spray within 4 weeks of baseline or during the study period.
Use of artificial tears within 2 hours prior to the baseline or study visit days.
Any known allergies to any component of the study drug.
Severe, uncontrolled autoimmune disease (e.g., rheumatoid arthritis, lupus). Uncontrolled is at the discretion of the PI. Subjects with severe systemic symptoms will not be included.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Venice?

Yes, this clinical trial (NCT07277257) has an active research site in Venice, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Sjogren Syndrome With Keratoconjunctivitis Treatment Options in Venice, FL

If you're searching for sjogren syndrome with keratoconjunctivitis treatment options in Venice, FL, this clinical trial (NCT07277257) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Venice research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced sjogren syndrome with keratoconjunctivitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all sjogren syndrome with keratoconjunctivitis clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Venice, FL

See all rheumatoid arthritis clinical trials recruiting in Venice — not just this study.

Browse Rheumatoid Arthritis Trials in Venice →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsSjogrens Syndrome TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Venice?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Venice, FL